C. Tosello

Statistics

Publications

Citations

H-Index

Active since

1997

Affiliations

C. Tosello is an author at Hospital Amaral Carvalho specializing in metastatic breast cancer treatment, breast cancer pharmacotherapy, and metastatic breast cancer.

ORCID

Publications per year

1997–2020

Publications

Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer (CLEOPATRA): end-of-study results from a double-blind, randomised, placebo-controlled, phase 3 study

Sandra M. Swain, David Miles, Sung‐Bae Kim et al. · The Lancet Oncology · 2020 · 898 citations

Medicine, Oncology, Pharmacology +14

Doubling epirubicin dose intensity (100 mg/m2 versus 50 mg/m2) in the FEC regimen significantly increases response rates. An international randomised phase III study in metastatic breast cancer

G Brufman, E Colajori, N. Ghilezan et al. · Annals of Oncology · 1997 · 79 citations · Full text

Medicine, Oncology, Pharmacology +15

A Phase II Randomized Study of Lapatinib Combined With Capecitabine, Vinorelbine, or Gemcitabine in Patients With HER2-Positive Metastatic Breast Cancer With Progression After a Taxane (Latin American Cooperative Oncology Group 0801 Study)

Henry Gómez, Silvia P. Neciosup, C. Tosello et al. · Clinical Breast Cancer · 2015 · 23 citations · Full text

Medicine, Oncology, Pharmacology +16

1–3 of 3